aTyr Pharma, Inc. (ATYR) vs Baird Medical Investment Holdings Limited (BDMD)
A side-by-side comparison of aTyr Pharma, Inc. and Baird Medical Investment Holdings Limited across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ATYR
aTyr Pharma, Inc.
$0.29HealthcareDelayed quote: Oct 6, 2026, 2:59 PM EDT
BDMD
Baird Medical Investment Holdings Limited
$0.75HealthcareDelayed quote: Oct 6, 2026, 2:59 PM EDT
Total return — ATYR vs BDMD
growth of $100 · dividends reinvested · last 2yATYR -83.2% (-59.1%/yr)BDMD -93.3% (-74.1%/yr)ATYR compounded faster over this window
ATYR BDMD
ATYR vs BDMD: by the numbers
- •BDMD is the larger company ($32M vs $28M market cap).
- •Both run net losses; BDMD's is the smaller (-121.04% vs -32003.68% net margin).
- •BDMD grew revenue faster over the past five years (4.46% vs -38.74% CAGR).
Metrics side by side
Valuation
| Metric | ATYR | BDMD |
|---|---|---|
| Forward P/E | N/A | 9.33 |
| P/S ratio | 149.61 | N/A |
| P/B ratio | 0.58 | 0.91 |
Profitability
| Metric | ATYR | BDMD |
|---|---|---|
| Gross margin | -717.37% | 83.79% |
| Operating margin | -40856.32% | -113.31% |
| Net margin | -32003.68% | -121.04% |
| ROE | -124.64% | -86.96% |
| ROIC | -109.29% | -50.66% |
Growth (annualized)
| Metric | ATYR | BDMD |
|---|---|---|
| Revenue CAGR (5Y) | -38.74% | 4.46% |
Frequently asked
- Which has grown faster, ATYR or BDMD?
- Over the past five years, BDMD grew revenue faster — ATYR at a -38.74% CAGR versus BDMD at 4.46%.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.